BACKGROUND: Although breast cancer is most prevalent among older women, the majority are diagnosed at an early stage. When diagnosed at an early stage, women have the option of breast-conserving surgery (BCS) plus radiation therapy (RT) or mastectomy for the treatment of early-stage breast cancer (ESBC). Omission of RT when receiving BCS increases the risk for recurrence and poor survival. Yet, a small subset of older women may omit RT after BCS. This study examines the current patterns of local treatment for ESBC among older women. METHODS: This study conducted a retrospective observational analysis using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked dataset of women age ≥66 diagnosed with stage I-II breast cancer in 2003-2009. SEER-Medicare data was additionally linked with data from the Area Resource File (ARF) to examine the association between area-level healthcare resources and treatment. Two logistic regression models were used to estimate how study factors were associated with receiving (1) BCS versus BCS+RT and (2) Mastectomy versus BCS+RT. A stratified analysis was also conducted among women aged <70 years. RESULTS: Among 45,924 patients, 55% received BCS+RT, 23% received mastectomy, and 22% received BCS only. Women of increasing age, comorbidity, primary care provider visits, stage II disease, and nonwhite race were more likely to have mastectomy or BCS only, than BCS+RT. Women diagnosed in 2004-2006, treated by an oncology surgeon, residing in metro areas, areas of greater education and income, were less likely to receive mastectomy or BCS only, than BCS+RT. While women aged <70 years were more likely to receive BCS+RT, socioeconomic and physician specialties were associated with receiving BCS only. CONCLUSIONS: Over half of older women with ESBC initially receive BCS+RT. The likelihood for mastectomy and BCS only increases with age, comorbidity, and vulnerable socio-demographic characteristics. Findings demonstrate continued treatment disparities among certain vulnerable populations.
BACKGROUND: Although breast cancer is most prevalent among older women, the majority are diagnosed at an early stage. When diagnosed at an early stage, women have the option of breast-conserving surgery (BCS) plus radiation therapy (RT) or mastectomy for the treatment of early-stage breast cancer (ESBC). Omission of RT when receiving BCS increases the risk for recurrence and poor survival. Yet, a small subset of older women may omit RT after BCS. This study examines the current patterns of local treatment for ESBC among older women. METHODS: This study conducted a retrospective observational analysis using the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked dataset of women age ≥66 diagnosed with stage I-II breast cancer in 2003-2009. SEER-Medicare data was additionally linked with data from the Area Resource File (ARF) to examine the association between area-level healthcare resources and treatment. Two logistic regression models were used to estimate how study factors were associated with receiving (1) BCS versus BCS+RT and (2) Mastectomy versus BCS+RT. A stratified analysis was also conducted among women aged <70 years. RESULTS: Among 45,924 patients, 55% received BCS+RT, 23% received mastectomy, and 22% received BCS only. Women of increasing age, comorbidity, primary care provider visits, stage II disease, and nonwhite race were more likely to have mastectomy or BCS only, than BCS+RT. Women diagnosed in 2004-2006, treated by an oncology surgeon, residing in metro areas, areas of greater education and income, were less likely to receive mastectomy or BCS only, than BCS+RT. While women aged <70 years were more likely to receive BCS+RT, socioeconomic and physician specialties were associated with receiving BCS only. CONCLUSIONS: Over half of older women with ESBC initially receive BCS+RT. The likelihood for mastectomy and BCS only increases with age, comorbidity, and vulnerable socio-demographic characteristics. Findings demonstrate continued treatment disparities among certain vulnerable populations.
Entities:
Keywords:
breast cancer; early-stage; elderly; treatment
Authors: Nicole L Simone; Tu Dan; Joanna Shih; Sharon L Smith; Linda Sciuto; Elena Lita; Marc E Lippman; Eli Glatstein; Sandra M Swain; David N Danforth; Kevin Camphausen Journal: Breast Cancer Res Treat Date: 2011-11-24 Impact factor: 4.872
Authors: Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren Journal: Am J Epidemiol Date: 2011-08-04 Impact factor: 4.897
Authors: Jeffrey M Albert; I-Wen Pan; Ya-Chen Tina Shih; Jing Jiang; Thomas A Buchholz; Sharon H Giordano; Benjamin D Smith Journal: Cancer Date: 2012-08-13 Impact factor: 6.860
Authors: Carrie Luu; Leanne Goldstein; Bryan Goldner; Hans F Schoellhammer; Steven L Chen Journal: Ann Surg Oncol Date: 2013-08-22 Impact factor: 5.344
Authors: M Kiderlen; E Bastiaannet; P M Walsh; N L Keating; S Schrodi; J Engel; W van de Water; S M Ess; L van Eycken; A Miranda; L de Munck; C J H van de Velde; A J M de Craen; G J Liefers Journal: Breast Cancer Res Treat Date: 2011-11-27 Impact factor: 4.872
Authors: Jean A McDougall; Linda S Cook; Mei-Tzu C Tang; Hannah M Linden; Beti Thompson; Christopher I Li Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-10-22 Impact factor: 4.090